{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T14:57:41Z","timestamp":1788620261639,"version":"build-2803163510"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T00:00:00Z","timestamp":1740096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T00:00:00Z","timestamp":1740096000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s00204-025-03986-5","type":"journal-article","created":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:24:57Z","timestamp":1740108297000},"page":"2133-2142","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Development of human growth hormone-treated chimeric mice with humanized livers for an evaluation model of drug-induced fatty liver disease"],"prefix":"10.1007","volume":"99","author":[{"given":"Sho","family":"Morioka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seigo","family":"Sanoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzue","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaichiro","family":"Kotake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2640-3268","authenticated-orcid":false,"given":"Chise","family":"Tateno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,21]]},"reference":[{"issue":"3","key":"3986_CR1","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/j.1365-2869.2004.00415.x","volume":"13","author":"G Brandenberger","year":"2004","unstructured":"Brandenberger G, Weibel L (2004) The 24-h growth hormone rhythm in men: sleep and circadian influences questioned. J Sleep Res 13(3):251\u2013255. https:\/\/doi.org\/10.1111\/j.1365-2869.2004.00415.x","journal-title":"J Sleep Res"},{"key":"3986_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/sciadv.adf4490","volume":"9","author":"M Carbonaro","year":"2023","unstructured":"Carbonaro M, Wang K, Huang H, Frleta D, Patel A, Pennington A, Desclaux M, Moller-Tank S, Grindley J, Altarejos J et al (2023) IL-6\u2013GP130 signaling protects human hepatocytes against lipid droplet accumulation in humanized liver models. Sci Adv 9:1\u201313. https:\/\/doi.org\/10.1126\/sciadv.adf4490","journal-title":"Sci Adv"},{"key":"3986_CR3","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1194\/jlr.m300135-jlr200","volume":"44","author":"JW Chisholm","year":"2003","unstructured":"Chisholm JW, Hong J, Mills SA, Lawn RM (2003) The LXR ligand T0901317 induces severe lipogenesis in the db\/db diabetic mouse. J Lipid Res 44:2039\u20132048. https:\/\/doi.org\/10.1194\/jlr.m300135-jlr200","journal-title":"J Lipid Res"},{"key":"3986_CR4","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.2337\/db15-0370","volume":"64","author":"J Cordoba-Chacon","year":"2015","unstructured":"Cordoba-Chacon J, Majumdar N, List EO, Diaz-Ruiz A, Frank SJ, Manzano A, Bartrons R, Puchowicz M, Kopchick JJ, Kineman RD (2015) Growth hormone inhibits hepatic de novo lipogenesis in adult mice. Diabetes 64:3093\u20133103. https:\/\/doi.org\/10.2337\/db15-0370","journal-title":"Diabetes"},{"key":"3986_CR5","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1002\/hep4.1953","volume":"6","author":"I Doycheva","year":"2022","unstructured":"Doycheva I, Erickson D, Watt KD (2022) Growth hormone deficiency and NAFLD: an overlooked and underrecognized link. Hepatol Commun 6:2227\u20132237. https:\/\/doi.org\/10.1002\/hep4.1953","journal-title":"Hepatol Commun"},{"key":"3986_CR6","doi-asserted-by":"publisher","first-page":"19937","DOI":"10.1074\/jbc.m109.014308","volume":"284","author":"Y Fan","year":"2009","unstructured":"Fan Y, Menon RK, Cohen P, Hwang D, Clemens T, DiGirolamo DJ, Kopchick JJ, Le Roith D, Trucco M, Sperling MA (2009) Liver-specific deletion of the growth hormone receptor reveals essential role of growth hormone signaling in hepatic lipid metabolism. J Biol Chem 284:19937\u201319944. https:\/\/doi.org\/10.1074\/jbc.m109.014308","journal-title":"J Biol Chem"},{"key":"3986_CR7","doi-asserted-by":"publisher","first-page":"E1232","DOI":"10.1152\/ajpendo.00134.2018","volume":"315","author":"K Fukunaga","year":"2018","unstructured":"Fukunaga K, Imachi H, Lyu J, Dong T, Sato S, Ibata T, Kobayashi T, Yoshimoto T, Yonezaki K, Matsunaga T et al (2018) IGF1 suppresses cholesterol accumulation in the liver of growth hormone-deficient mice via the activation of ABCA1. Am J Physiol Endocrinol Metab 315:E1232\u2013E1241. https:\/\/doi.org\/10.1152\/ajpendo.00134.2018","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"3986_CR8","doi-asserted-by":"publisher","first-page":"34182","DOI":"10.1074\/jbc.m204887200","volume":"277","author":"A Grefhorst","year":"2002","unstructured":"Grefhorst A, Elzinga BM, Voshol PJ, Pl\u00f6sch T, Kok T, Bloks VW, Van Der Sluijs FH, Havekes LM, Romijn JA, Verkade HJ et al (2002) Stimulation of lipogenesis by pharmacological activation of the liver X receptor leads to production of large, triglyceride-rich very low density lipoprotein particles. J Biol Chem 277:34182\u201334190. https:\/\/doi.org\/10.1074\/jbc.m204887200","journal-title":"J Biol Chem"},{"issue":"1","key":"3986_CR9","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","volume":"6","author":"X Hu","year":"2021","unstructured":"Hu X, Li J, Fu M, Zhao X, Wang W (2021) The JAK\/STAT signaling pathway: from bench to clinic. Signal Transduct Target Ther 6(1):402. https:\/\/doi.org\/10.1038\/s41392-021-00791-1","journal-title":"Signal Transduct Target Ther"},{"key":"3986_CR10","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1210\/me.2002-0191","volume":"17","author":"T Ide","year":"2003","unstructured":"Ide T, Shimano H, Yoshikawa T, Yahagi N, Amemiya-Kudo M, Matsuzaka T, Nakakuki M, Yatoh S, Iizuka Y, Tomita S et al (2003) Cross-talk between peroxi-some proliferator-activated receptor (PPAR) \u03b1 and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. II. LXRs suppress lipid degradation gene promoters through inhibition of PPAR signaling. J Mol Endocrinol 17:1255\u20131267. https:\/\/doi.org\/10.1210\/me.2002-0191","journal-title":"J Mol Endocrinol"},{"key":"3986_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0239540","volume":"15","author":"Y Ishida","year":"2020","unstructured":"Ishida Y, Yamasaki C, Iwanari H, Yamashita H, Ogawa Y, Yanagi A, Furukawa S, Kojima Y, Chayama K, Kamiie J et al (2020) Detection of acute toxicity of aflatoxin B1 to human hepatocytes in vitro and in vivo using chimeric mice with humanized livers. PLoS ONE 15:1\u201316. https:\/\/doi.org\/10.1371\/journal.pone.0239540","journal-title":"PLoS ONE"},{"key":"3986_CR12","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1507\/endocrj.ej12-0110","volume":"59","author":"T Isojima","year":"2012","unstructured":"Isojima T, Shimatsu A, Yokoya S, Chihara K, Tanaka T, Hizuka N, Teramoto A, Tatsumi KI, Tachibana K, Katsumata N et al (2012) Standardized centile curves and reference intervals of serum insulin-like growth factor-I (IGF-I) levels in a normal Japanese population using the LMS method. Endocr J 59:771\u2013780. https:\/\/doi.org\/10.1507\/endocrj.ej12-0110","journal-title":"Endocr J"},{"key":"3986_CR13","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.toxlet.2012.08.001","volume":"214","author":"M Kakuni","year":"2012","unstructured":"Kakuni M, Morita M, Matsuo K, Katoh Y, Nakajima M, Tateno C, Yokoi T (2012) Chimeric mice with a humanized liver as an animal model of troglitazone-induced liver injury. Toxicol Lett 214:9\u201318. https:\/\/doi.org\/10.1016\/j.toxlet.2012.08.001","journal-title":"Toxicol Lett"},{"key":"3986_CR14","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1124\/dmd.105.005157","volume":"33","author":"M Katoh","year":"2005","unstructured":"Katoh M, Matsui T, Okumura H, Nakajima M, Nishimura M, Naito S, Tateno C, Yoshizato K, Yokoi T (2005) Expression of human phase II enzymes in chimeric mice with humanized liver. Drug Metab Dispos 33:1333\u20131340. https:\/\/doi.org\/10.1124\/dmd.105.005157","journal-title":"Drug Metab Dispos"},{"key":"3986_CR15","doi-asserted-by":"publisher","first-page":"106","DOI":"10.5483\/bmbrep.2021.54.2.111","volume":"54","author":"JK Kim","year":"2021","unstructured":"Kim JK, Cho IJ, Kim EO, Lee DG, Jung DH, Ki SH, Ku SK, Kim SC (2021) Hemistepsin A inhibits T0901317-induced lipogenesis in the liver. BMB Rep 54:106\u2013111. https:\/\/doi.org\/10.5483\/bmbrep.2021.54.2.111","journal-title":"BMB Rep"},{"key":"3986_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/biomedicines9111647","volume":"9","author":"K Kisoh","year":"2021","unstructured":"Kisoh K, Sugahara G, Ogawa Y, Furukawa S, Ishida Y, Okanoue T, Kohara M, Tateno C (2021) Estimating drug efficacy with a diet-induced nash model in chimeric mice with humanized livers. Biomedicines 9:1\u201319. https:\/\/doi.org\/10.3390\/biomedicines9111647","journal-title":"Biomedicines"},{"key":"3986_CR17","doi-asserted-by":"publisher","first-page":"601","DOI":"10.2131\/jts.46.601","volume":"46","author":"K Matsunaga","year":"2021","unstructured":"Matsunaga K, Abe J, Ogata K, Fukunaga S, Kitamoto S (2021) Elucidation of the species differences of epyrifenacil-induced hepatotoxicity between mice and humans by mass spectrometry imaging analysis in chimeric mice with humanized liver. J Toxicol Sci 46:601\u2013609. https:\/\/doi.org\/10.2131\/jts.46.601","journal-title":"J Toxicol Sci"},{"key":"3986_CR18","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1016\/j.jhep.2014.12.034","volume":"62","author":"M Mueller","year":"2015","unstructured":"Mueller M, Thorell A, Claudel T, Jha P, Koefeler H, Lackner C, Hoesel B, Fauler G, Stojakovic T, Einarsson C et al (2015) Ursodeoxycholic acid exerts farnesoid X receptor-antagonistic effects on bile acid and lipid metabolism in morbid obesity. J Hepatol 62:1398\u20131404. https:\/\/doi.org\/10.1016\/j.jhep.2014.12.034","journal-title":"J Hepatol"},{"key":"3986_CR19","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1093\/toxsci\/kfy228","volume":"167","author":"K Nihira","year":"2019","unstructured":"Nihira K, Nan-Ya KI, Kakuni M, Ono Y, Yoshikawa Y, Ota T, Hiura M, Yoshinari K (2019) Chimeric mice with humanized livers demonstrate human-specific hepatotoxicity caused by a therapeutic antibody against TRAIL-Receptor 2\/Death Receptor 5. Toxicol Sci 167:92\u2013104. https:\/\/doi.org\/10.1093\/toxsci\/kfy228","journal-title":"Toxicol Sci"},{"key":"3986_CR20","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2131\/jts.48.99","volume":"48","author":"Y Ohtsuki","year":"2023","unstructured":"Ohtsuki Y, Sanoh S, Yamao M, Kojima Y, Kotake Y, Tateno C (2023) Establishment of hyperoxic cell culture system for predicting drug-induced liver injury: reducing accumulated lipids in hepatocytes derived from chimeric mice with humanized liver. J Toxicol Sci 48:99\u2013108. https:\/\/doi.org\/10.2131\/jts.48.99","journal-title":"J Toxicol Sci"},{"key":"3986_CR21","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1093\/toxsci\/kfm041","volume":"97","author":"H Okumura","year":"2007","unstructured":"Okumura H, Katoh M, Sawada T, Nakajima M, Soeno Y, Yabuuchi H, Ikeda T, Tateno C, Yoshizato K, Yokoi T (2007) Humanization of excretory pathway in chimeric mice with humanized liver. Toxicol Sci 97:533\u2013538. https:\/\/doi.org\/10.1093\/toxsci\/kfm041","journal-title":"Toxicol Sci"},{"key":"3986_CR22","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1111\/j.1365-2826.2010.01994.x","volume":"22","author":"S Sangiao-Alvarellos","year":"2010","unstructured":"Sangiao-Alvarellos S, Varela L, V\u00e1zquez MJ, Da Boit K, Saha AK, Cordido F, Di\u00e9guez C, L\u00f3pez M (2010) Influence of ghrelin and growth hormone deficiency on amp-activated protein kinase and hypothalamic lipid metabolism. J Neuroendocrinol 22:543\u2013556. https:\/\/doi.org\/10.1111\/j.1365-2826.2010.01994.x","journal-title":"J Neuroendocrinol"},{"key":"3986_CR23","doi-asserted-by":"publisher","first-page":"589","DOI":"10.2131\/jts.42.589","volume":"42","author":"S Sanoh","year":"2017","unstructured":"Sanoh S, Yamachika Y, Tamura Y, Kotake Y, Yoshizane Y, Ishida Y, Tateno C, Ohta S (2017) Assessment of amiodarone-induced phospholipidosis in chimeric mice with a humanized liver. J Toxicol Sci 42:589\u2013596. https:\/\/doi.org\/10.2131\/jts.42.589","journal-title":"J Toxicol Sci"},{"key":"3986_CR24","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1073\/pnas.92.4.959","volume":"92","author":"SC Souza","year":"1995","unstructured":"Souza SC, Frick GP, Wang X, Kopchick JJ, Lobo RB, Goodman HM (1995) A single arginine residue determines species specificity of the human growth hormone receptor. Proc Natl Acad Sci U S A 92:959\u2013963. https:\/\/doi.org\/10.1073\/pnas.92.4.959","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3986_CR25","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1111\/hepr.12408","volume":"45","author":"Y Sumida","year":"2015","unstructured":"Sumida Y, Yonei Y, Tanaka S, Mori K, Kanemasa K, Imai S, Taketani H, Hara T, Seko Y, Ishiba H et al (2015) Lower levels of insulin-like growth factor-1 standard deviation score are associated with histological severity of non-alcoholic fatty liver disease. Hepatol Res 45:771\u2013781. https:\/\/doi.org\/10.1111\/hepr.12408","journal-title":"Hepatol Res"},{"key":"3986_CR26","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1172\/jci105893","volume":"47","author":"Y Takahashi","year":"1968","unstructured":"Takahashi Y, Kipnis DM, Daughaday WH (1968) Growth hormone secretion during sleep. J Clin Invest 47:2079\u20132090. https:\/\/doi.org\/10.1172\/jci105893","journal-title":"J Clin Invest"},{"key":"3986_CR27","doi-asserted-by":"publisher","first-page":"21090","DOI":"10.1074\/jbc.m701228200","volume":"282","author":"N Tamehiro","year":"2007","unstructured":"Tamehiro N, Shigemoto-Mogami Y, Kakeya T, Okuhira KI, Suzuki K, Sato R, Nagao T, Nishimaki-Mogami T (2007) Sterol regulatory element-binding protein-2- and liver X receptor-driven dual promoter regulation of hepatic ABC transporter A1 gene expression: mechanism underlying the unique response to cellular cholesterol status. J Biol Chem 282:21090\u201321099. https:\/\/doi.org\/10.1074\/jbc.m701228200","journal-title":"J Biol Chem"},{"key":"3986_CR28","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/s0002-9440(10)63352-4","volume":"165","author":"C Tateno","year":"2004","unstructured":"Tateno C, Yoshizane Y, Saito N, Kataoka M, Utoh R, Yamasaki C, Tachibana A, Soeno Y, Asahina K, Hino H et al (2004) Near completely humanized liver in mice shows human-type metabolic responses to drugs. Am J Pathol 165:901\u2013912. https:\/\/doi.org\/10.1016\/s0002-9440(10)63352-4","journal-title":"Am J Pathol"},{"key":"3986_CR29","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1210\/en.2010-0953","volume":"152","author":"C Tateno","year":"2011","unstructured":"Tateno C, Kataoka M, Utoh R, Tachibana A, Itamoto T, Asahara T, Miya F, Tsunoda T, Yoshizato K (2011) Growth hormone-dependent pathogenesis of human hepatic steatosis in a novel mouse model bearing a human hepatocyte-repopulated liver. Endocrinology 152:1479\u20131491. https:\/\/doi.org\/10.1210\/en.2010-0953","journal-title":"Endocrinology"},{"key":"3986_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0142145","volume":"10","author":"C Tateno","year":"2015","unstructured":"Tateno C, Kawase Y, Tobita Y, Hamamura S, Ohshita H, Yokomichi H, Sanada H, Kakuni M, Shiota A, Kojima Y et al (2015) Generation of novel Chimeric mice with humanized livers by using hemizygous cDNA-uPA\/SCID mice. PLoS ONE 10:1\u201320. https:\/\/doi.org\/10.1371\/journal.pone.0142145","journal-title":"PLoS ONE"},{"key":"3986_CR31","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.mrgentox.2019.01.003","volume":"839","author":"C Tateno","year":"2019","unstructured":"Tateno C, Fukumuro M, Masumori S, Kakuni M, Ishida Y, Shimada T, Hayashi M (2019) Chimeric mice with human hepatocytes: a new system for genotoxicity studies. Muta Res Genet Toxicol Environ Mutagen 839:9\u201312. https:\/\/doi.org\/10.1016\/j.mrgentox.2019.01.003","journal-title":"Muta Res Genet Toxicol Environ Mutagen"},{"key":"3986_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2023.155589","volume":"144","author":"MC V\u00e1zquez-Borrego","year":"2023","unstructured":"V\u00e1zquez-Borrego MC, Del R\u00edo-Moreno M, Pyatkov M, Sarmento-Cabral A, Mahmood M, Pelke N, Wnek M, Cordoba-Chacon J, Waxman DJ, Puchowicz MA et al (2023) Direct and systemic actions of growth hormone receptor (GHR)-signaling on hepatic glycolysis, de novo lipogenesis and insulin sensitivity, associated with steatosis. Metabolism 144:155589. https:\/\/doi.org\/10.1016\/j.metabol.2023.155589","journal-title":"Metabolism"},{"key":"3986_CR33","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/nm0102-75","volume":"8","author":"V Wallenius","year":"2002","unstructured":"Wallenius V, Wallenius K, Ahr\u00e9n B, Rudling M, Carlsten H, Dickson SL, Ohlsson C, Jansson JO (2002) Interleukin-6-deficient mice develop mature-onset obesity. Nat Med 8:75\u201379. https:\/\/doi.org\/10.1038\/nm0102-75","journal-title":"Nat Med"},{"key":"3986_CR34","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1093\/toxsci\/kfaa125","volume":"177","author":"T Yamada","year":"2020","unstructured":"Yamada T, Ohara A, Ozawa N, Maeda K, Kondo M, Okuda Y, Abe J, Cohen SM, Lake BG (2020) Comparison of the hepatic effects of phenobarbital in chimeric mice containing either rat or human hepatocytes with humanized constitutive androstane receptor and pregnane X receptor mice. Toxicol Sci 177:362\u2013376. https:\/\/doi.org\/10.1093\/toxsci\/kfaa125","journal-title":"Toxicol Sci"},{"key":"3986_CR35","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1039\/c4tx00068d","volume":"4","author":"H Yamazaki","year":"2015","unstructured":"Yamazaki H, Kuribayashi S, Inoue T, Honda T, Tateno C, Oofusa K, Ninomiya S, Ikeda T, Izumi T, Horie T (2015) Zone analysis by two-dimensional electrophoresis with accelerator mass spectrometry of in vivo protein bindings of idiosyncratic hepatotoxicants troglitazone and flutamide bioactivated in chimeric mice with humanized liver. Toxicol Res 4:106\u2013111. https:\/\/doi.org\/10.1039\/c4tx00068d","journal-title":"Toxicol Res"},{"key":"3986_CR36","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1515\/hmbci.2011.125","volume":"8","author":"F Zadjali","year":"2011","unstructured":"Zadjali F, Santana-Farre R, Mirecki-Garrido M, Ellis E, Norstedt G, Fernandez-Perez L, Flores-Morales A (2011) Liver X receptor agonist downregulates growth hormone signaling in the liver. HMBCI 8:471\u2013478. https:\/\/doi.org\/10.1515\/hmbci.2011.125","journal-title":"HMBCI"},{"key":"3986_CR37","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1172\/jci59817","volume":"122","author":"Y Zhang","year":"2012","unstructured":"Zhang Y, Breevoort SR, Angdisen J, Fu M, Schmidt DR, Holmstrom SR, Kliewer SA, Man-gelsdorf DJ, Schulman IG (2012) Liver LXR\u03b1 expression is crucial for whole body cholesterol homeostasis and reverse cholesterol transport in mice. J Clin Invest 122:1688\u20131699. https:\/\/doi.org\/10.1172\/jci59817","journal-title":"J Clin Invest"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-025-03986-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00204-025-03986-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-025-03986-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T07:49:25Z","timestamp":1747468165000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00204-025-03986-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,21]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["3986"],"URL":"https:\/\/doi.org\/10.1007\/s00204-025-03986-5","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,21]]},"assertion":[{"value":"6 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Sho Morioka, Yuji Ishida, Suzue Furukawa, Yuko Ogawa, Chise Tateno are employees of PhoenixBio Co., Ltd. Seigo Sanoh received financial support from PhoenixBio Co. Ltd. for the collaborative study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures involving human hepatocytes were approved by the Utilization of Human Tissue Ethical Committee of Phoenix Bio Co., Ltd. All experimental procedures involving animals were conducted in accordance with the guidelines provided by the Proper Conduct of Animal Experiments (June 1, 2006; Science Council of Japan). All procedures were approved by the Laboratory Animal Ethics Committee of Phoenix Bio Co., Ltd.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}